Royal Bank of Canada’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,456
Closed -$66K 7767
2022
Q4
$66K Sell
2,456
-1,430
-37% -$37.6K ﹤0.01% 5739
2022
Q3
$70K Sell
3,886
-52,025
-93% -$831K ﹤0.01% 5552
2022
Q2
$695K Sell
55,911
-62,576
-53% -$691K ﹤0.01% 3806
2022
Q1
$1.58M Sell
118,487
-42,535
-26% -$570K ﹤0.01% 3260
2021
Q4
$2.51M Buy
161,022
+6,789
+4% +$130K ﹤0.01% 2957
2021
Q3
$3.46M Buy
154,233
+152,453
+8,565% +$3.35M ﹤0.01% 2605
2021
Q2
$41K Buy
1,780
+300
+20% +$6.31K ﹤0.01% 6175
2021
Q1
$31K Buy
1,480
+1,005
+212% +$22.9K ﹤0.01% 6190
2020
Q4
$13K Buy
475
+100
+27% +$1.95K ﹤0.01% 6280
2020
Q3
$5K Buy
375
+155
+70% +$2.88K ﹤0.01% 6152
2020
Q2
$5K Buy
220
+20
+10% +$272 ﹤0.01% 6069
2020
Q1
$2K Hold
200
﹤0.01% 6361
2019
Q4
$3K Buy
+200
New +$2.02K ﹤0.01% 6513
2018
Q4
Sell
-2,500
Closed -$66K 7282
2018
Q3
$66K Buy
+2,500
New +$56.6K ﹤0.01% 5092
2018
Q2
Sell
-3
Closed 6874
2018
Q1
$0 Buy
3
+1
+50% +$15 ﹤0.01% 6950
2017
Q4
$0 Hold
2
﹤0.01% 7029
2017
Q3
$0 Buy
+2
New +$24 ﹤0.01% 7086
2017
Q2
Sell
-230
Closed -$3K 6867
2017
Q1
$3K Sell
230
-338
-60% -$3.88K ﹤0.01% 6379
2016
Q4
$7K Buy
+568
New +$6.58K ﹤0.01% 6223

Other funds holding MYOV

Royal Bank of Canada's MYOV Position: Q1 2023 in Review

Royal Bank of Canada sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 2,456 shares — an estimated $66K sold.

Royal Bank of Canada first reported a position in MYOV in Q4 2016 and held it in 19 quarters. The position peaked at $3.46M in Q3 2021. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Royal Bank of Canada reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 2,456 Myovant Sciences Ltd. shares in Q1 2023, an estimated $66K.
  • Royal Bank of Canada first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 19 quarters.
  • Royal Bank of Canada's Myovant Sciences Ltd. position peaked at $3.46M in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.